Immunotherapy targeting tumor‐associated antigen in a mouse model of head and neck cancer
Head & Neck · 2024
DOI: 10.1002/hed.27703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2024. Verfasst von Michihisa Kono und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, Asahikawa Medical University, Asahikawa, Japan. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Cancer Vaccines, Immunotherapy, Disease Models, Animal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
The identification of epitope peptides from tumor‐associated antigens (TAAs) is informative for developing tumor‐specific immunotherapy. However, only a few epitopes have been detected in mouse TAAs of head and neck cancer (HNSCC).
Methods
Novel mouse c‐Met‐derived T‐cell epitopes were predicted by computer‐based algorithms. Mouse HNSCC cell line‐bearing mice were treated with a c‐Met peptide vaccine. The effects of CD8 and/or CD4 T‐cell depletion, and vaccine combination with immune checkpoint inhibitors (ICIs) were evaluated. Tumor re‐inoculation was performed to assess T‐cell memory.
Results
We identified c‐Met‐derived short and long epitopes that elicited c‐Met‐reactive antitumor CD8 and/or CD4 T‐cell responses. Vaccination using these peptides showed remarkable antitumor responses via T cells in which ICIs were not required. The c‐Met peptide‐vaccinated mice rejected the re‐inoculated tumors.
Conclusions
We demonstrated that novel c‐Met peptide vaccines can induce antitumor T‐cell response, and could be a potent immunotherapy in a syngeneic mouse HNSCC model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head & Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
- Department of Innovative Head & Neck Cancer Research and Treatment, Asahikawa Medical University, Asahikawa, Japan.
- Department of Pathology, Asahikawa Medical University, Asahikawa, Japan.
ORCID-Profile: Michihisa Kono, Takumi Kumai
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Kono, M., Wakisaka, R., Komatsuda, H., Hayashi, R., Kumai, T., Yamaki, H., Sato, R., Nagato, T., Ohkuri, T., Kosaka, A., Ohara, K., Kishibe, K., Kobayashi, H., Hayashi, T., & Takahara, M. (2024). Immunotherapy targeting tumor‐associated antigen in a mouse model of head and neck cancer. Head & Neck. https://doi.org/10.1002/hed.27703
Vancouver
Kono M, Wakisaka R, Komatsuda H, Hayashi R, Kumai T, Yamaki H, et al. Immunotherapy targeting tumor‐associated antigen in a mouse model of head and neck cancer. Head & Neck. 2024. doi:10.1002/hed.27703
BibTeX
@article{Kono2024,
author = {Kono, Michihisa and Wakisaka, Risa and Komatsuda, Hiroki and Hayashi, Ryusuke and Kumai, Takumi and Yamaki, Hidekiyo and Sato, Ryosuke and Nagato, Toshihiro and Ohkuri, Takayuki and Kosaka, Akemi and Ohara, Kenzo and Kishibe, Kan and Kobayashi, Hiroya and Hayashi, Tatsuya and Takahara, Miki},
title = {Immunotherapy targeting tumor‐associated antigen in a mouse model of head and neck cancer},
journal = {Head & Neck},
year = {2024},
doi = {10.1002/hed.27703}
}
EUVIMED